Leptin and the Regulation of the Hypothalamic–Pituitary–Adrenal Axis

https://doi.org/10.1016/S0074-7696(07)63002-2Get rights and content

Abstract

Leptin, the product of the obesity gene (ob) predominantly secreted from adipocytes, plays a major role in the negative control of feeding and acts via a specific receptor (Ob‐R), six isoforms of which are known at present. Evidence has been accumulated that leptin, like other peptides involved in the central regulation of food intake, controls the function of the hypothalamic–pituitary–adrenal (HPA) axis, acting on both its central and peripheral branches. Leptin, along with Ob‐R, is expressed in the hypothalamus and pituitary gland, where it modulates corticotropin‐releasing hormone and ACTH secretion, probably acting in an autocrine–paracrine manner. Only Ob‐R is expressed in the adrenal gland, thereby making it likely that leptin affects it by acting as a circulating hormone. Although in vitro and in vivo findings could suggest a glucocorticoid secretagogue action in the rat, the bulk of evidence indicates that leptin inhibits steroid‐hormone secretion from the adrenal cortex. In keeping with this, leptin was found to dampen the HPA axis response to many kinds of stress. In contrast, leptin enhances catecolamine release from the adrenal medulla. This observation suggests that leptin activates the sympathoadrenal axis and does not appear to agree with its above‐mentioned antistress action. Leptin and/or Ob‐R are also expressed in pituitary and adrenal tumors, but little is known about the role of this cytokine in the pathophysiology.

Introduction

Leptin (from the Greek λεπτóς, thin) is a 147‐amino acid residue peptide, first described by Zhang et al. (1994). It is the product of the obesity gene (ob) and is predominantly secreted by adipocytes and stomach (Myers 2004, Zhang 1994, Zhang 2005). Leptin plays a role in the control of feeding, acting to decrease caloric intake and to increase energy expenditure (Ahima 2000, Mantzoros 1998, Myers 2004, Remesar 1997, Unger 2000, Zhang 2005).

Compelling evidence indicates that peptides involved in the regulation of food intake (e.g., beacon, cholecystokinin, galanin, neuropeptide‐W, neuropeptide‐Y, and orexins) (Baker 2003, Bedecs 1995, Cerda‐Reverter 2000, Collier 2000, Crawley 1994, Wolf 1998) control the function of the hypothalamic–pituitary–adrenal (HPA) axis, acting on both its central and peripheral branch (Andreis 2005, Andreis 2007, Hochól 2007, Krysiak 1999, Malendowicz 1994, Malendowicz 2003b, Mazzocchi 1998, Mazzocchi 2005, Nussdorfer 2005, Rucinski 2005a, Rucinski 2005b, Spinazzi 2005, Spinazzi 2006). Accordingly, leptin also regulates neuroendocrine axes, including the HPA one (Ahima 2000, Bates 2003, Casanueva 1999, Sahu 2003, Wauters 2000).

The interactions of peptides regulating food intake, and especially leptin, with the HPA axis are of great relevance, inasmuch as glucocorticoid hormones are known to be involved in the control of energy homeostasis and adipogenesis (Jeong 2004, Mastorakos 2004). At low concentrations, glucocorticoids exert anabolic effects and stimulate feeding, adipocyte differentiation, and normal fat deposition (Campfield 1996, Dallman 1993, Freedman 1986, Hauner 1987). The permissive role of glucocorticoids in the development of obesity is suggested by experiments showing that adrenalectomy prevents the progression of obesity in genetically obese Zucker rats (Freedman et al., 1986) and high doses of glucocorticoids cause excessive fat storage (Davenport et al., 1989). On the other hand, glucocorticoids have been reported to enhance leptin expression in and secretion from adipocytes (Slieker 1996, Zakrzewska 1997), an effect that could dampen their anabolic action.

Despite the large number of investigations carried out in the past 12 years and the physiological relevance of the matter, only two short survey articles have been published on the role of leptin in the regulation of the HPA axis (Glasow 2000, Wauters 2000). Thus, after a brief account of the biology of the leptin system, we will review findings indicating that leptin and/or its receptors (R) are expressed in the anatomical components of the HPA axis and that leptin plays a role in the functional regulation of the HPA axis under both physiological and pathological conditions.

Section snippets

Biosynthesis and secretion

The human ob gene is located on chromosome 7q31.3, has more that 15,000 base pairs, and consists of three exons and two introns. It encodes for the leptin precursor, peptides of 167 amino acids including the 21 residues of the signal peptide (Fig. 2.1). The tertiary structure of the leptin molecule resembles that of the members of the growth hormone (GH) four‐helical cytokine subfamily (Zhang et al., 2005). There is considerable homology in the leptin sequence among the various mammalian

Leptin

Available data on ob gene expression in the hypothalamus are few and rather conflicting. Reverse transcription (RT)‐polymerase chain reaction (PCR) and immunocytochemistry (ICC), but not Western blotting, detected leptin mRNA and protein in the rat hypothalamus (Morash et al., 1999). In subsequent studies, semiquantitative PCR analysis did not evidence age‐related changes in leptin mRNA expression in the female rat hypothalamus from day 2 to day 28 of postnatal life (Morash et al., 2001).

CRH expression and biosynthesis

Earlier studies showed that the intracerebroventricular (icv) injection of leptin raised by about 40% CRH mRNA in the PVN of normal rats, but not leptin‐resistant Zucker animals (Schwartz et al., 1996a), as well as induced c‐fos protein in the parvocellular division of PVN (Elmquist 1998, Masaki 2003, Van Dijk 1996). There is also an indication that icv leptin administration specifically activated CRH sympathetic neurons giving rise to descending autonomic transmission (Elmquist 1997, Okamoto

Humans

Pralong et al. (1998) reported that the 24‐ (but not 6‐) h exposure to leptin inhibited ACTH‐stimulated, but not basal, cortisol secretion from primary cultures of human adrenocortical cells, and subsequent studies confirmed this observation (Glasow 2000, Glasow 1998). It was shown that leptin lowered ACTH‐stimulated aldosterone secretion by about 30% and lowered cortisol and dehydroepiandrosterone (DHEA) yield by about 15% and that the drop in cortisol secretion was associated with a 50%

Response to stresses

Leptin has been reported to dampen the HPA axis response (ACTH and/or glucocorticoid secretion) to an unpredictable situation in monkeys (Wilson et al., 2005) and starvation in mice (Ahima 1996, Ziotopoulou 2000). HPA axis activation by metabolic stress (glucose deprivation by means of 2‐deoxyglucose administration), insulin‐induced hypoglycemia, and restraint stress were also blunted by leptin in the rat (Giovanbattista 2000, Heiman 1997, Nagatani 2001). However, in the rat only the

Concluding Remarks

The preceding sections have shown that leptin plays a relevant role in the regulation of the HPA axis. Leptin and its R are both expressed in the central branch of the HPA axis, where they can modulate CRH and ACTH secretion acting in an autocrine–paracrine manner. In contrast, only leptin R is expressed in the adrenal gland, suggesting that leptin affects the peripheral branch of the HPA axis exclusively, acting as a circulating hormone. The levels of circulating leptin are in the nanomolar

Acknowledgments

We wish to thank Miss Alberta Coi for her secretarial support and invaluable help in the provision of bibliographic items.

References (234)

  • F.F. Casanueva et al.

    Neuroendocrine regulation and actions of leptin

    Front. Neuroendocrinol.

    (1999)
  • R.A. Chavez et al.

    Targeting of leptin to the regulated secretory pathway in pituitary AtT‐20 cells

    Curr. Biol.

    (1997)
  • P.K. Chelikani et al.

    Tissue distribution of leptin and leptin receptor mRNA in the bovine

    J. Dairy Sci.

    (2003)
  • J.N. Crawley et al.

    Biological actions of cholecystokinin

    Peptides

    (1994)
  • K. Czaja et al.

    Distribution of neurons containing leptin receptors in the hypothalamus of the pig

    Biochem. Biophys. Res. Commun.

    (2002)
  • M.F. Dallman et al.

    Feast and famine: Critical role of glucocorticoids with insulin in daily energy flow

    Front. Neuroendocrinol.

    (1993)
  • S. Dridi et al.

    Mode of leptin action in chicken hypothalamus

    Brain Res.

    (2005)
  • C.J. Dyer et al.

    Leptin receptor mRNA is expressed in ewe anterior pituitary and adipose tissues and is differentially expressed in hypothalamic regions of well fed and feed‐restricted ewes

    Domest. Anim. Endocrinol.

    (1997)
  • M. Engelmann et al.

    The hypothalamic‐neurohypophyseal system regulates the hypothalamic‐pituitary‐adrenal axis under stress: An old concept revisited

    Front. Neuroendocrinol.

    (2004)
  • P. Grasso et al.

    Epitope mapping of secreted mouse leptin utilizing peripherally administered synthetic peptides

    Regul. Pept.

    (1999)
  • K. Hegyi et al.

    Leptin‐induced signal transduction pathways

    Cell Biol. Int.

    (2004)
  • N. Hoggard et al.

    Localization of leptin receptor splice variants in murine peripheral tissues by RT‐PCR and in situ hybridization

    Biochem. Biophys. Res. Commun.

    (1997)
  • K. Imagawa et al.

    Structure‐function studies of human leptin

    J. Biol. Chem.

    (1998)
  • J. Iqbal et al.

    Immunohistochemical characterization of localization of long‐form leptin receptor (Ob‐Rb) in neurochemically defined cells in the ovine hypothalamus

    Brain Res.

    (2001)
  • M. Isono et al.

    Significance of leptin expression in invasive potential of pituitary adenomas

    Clin. Neurol. Neurosurg.

    (2003)
  • M. Jang et al.

    Leptin rapidly inhibits hypothalamic neuropeptide Y secretion and stimulates corticotrophin‐releasing hormone secretion in adrenalectomized mice

    J. Nutr.

    (2000)
  • R.S. Ahima et al.

    Leptin

    Annu. Rev. Physiol.

    (2000)
  • R.S. Ahima et al.

    Role of leptin in the neuroendocrine response to fasting

    Nature

    (1996)
  • B. Ahren et al.

    Pharmacokinetics of human leptin in mice and rhesus monkeys

    Int. J. Obes. Relat. Metab. Disord.

    (2000)
  • P.G. Andreis et al.

    Neuropeptides B and W enhance the growth of human adrenocortical carcinoma‐derived NCI‐H295 cells by exerting MAPK p42/p44‐mediated proliferogenic and antiapoptotic effects

    Int. J. Mol. Med.

    (2005)
  • P.G. Andreis et al.

    Galanin enhances corticosterone secretion from dispersed rat adrenocortical cells through the activation of GAL‐R1 and GAL‐R2 receptors coupled to the adenylate cyclase‐dependent signaling cascade

    Int. J. Mol. Med.

    (2007)
  • S.R. Antonini et al.

    Expression of ACTH receptor pathway genes in glucose‐dependent insulinotrophic peptide (GIP)‐dependent Cushing's syndrome

    Clin. Endocrinol. (Oxf.)

    (2006)
  • K. Arvaniti et al.

    Effects of leptin and corticosterone on the expression of corticotrophin‐releasing hormone, agouti‐related protein, and proopiomelanocortin in the brain of ob/ob mouse

    Neuroendocrinology

    (2001)
  • J.R. Baker et al.

    Neuropeptide W acts in brain to control prolactin, corticosterone, and growth hormone release

    Endocrinology

    (2003)
  • R. Baldelli et al.

    The role of leptin in reproduction: Experimental and clinical aspects

    Ann. Med.

    (2002)
  • D. Barkan et al.

    Leptin modulates the glucocorticoid‐induced ovarian steroidogenesis

    Endocrinology

    (1999)
  • V.A. Barr et al.

    Insulin stimulates both leptin secretion and production by rat white adipose tissue

    Endocrinology

    (1997)
  • J. Bertherat et al.

    In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin‐independent macronodular adrenal hyperplasia causing Cushing's syndrome: Identification of two cases of gonadotropin/gastric inhibitory polypeptide‐dependent hypercortisolism

    J. Clin. Endocrinol. Metab.

    (2005)
  • A. Biason‐Lauber et al.

    Effect of leptin on CYP17 enzymatic activities in human adrenal cells: New insight in the onset of adrenarche

    Endocrinology

    (2000)
  • S.R. Bornstein et al.

    Leptin and the renin‐angiotensin‐aldosterone system

    Hypertension

    (1998)
  • S.R. Bornstein et al.

    Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: Leptin inhibits cortisol release

    Diabetes

    (1997)
  • S.R. Bornstein et al.

    Plasma leptin levels are increased in survivors of acute sepsis: Associated loss of diurnal rhythm in cortisol and leptin secretion

    J. Clin. Endocrinol. Metab.

    (1998)
  • I. Bourdeau et al.

    Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators

    Oncogene

    (2004)
  • J.D. Brannian et al.

    Leptin inhibits gonadotropin‐stimulated granulosa cell progesterone production by antagonizing insulin action

    Hum. Reprod.

    (1999)
  • B. Burguera et al.

    The long form of the leptin receptor (OB‐Rb) is widely expressed in the human brain

    Neuroendocrinology

    (2000)
  • A. Cai et al.

    Upregulation of leptin receptor gene expression in the anterior pituitary of human growth hormone‐releasing hormone transgenic mice

    Endocrinology

    (1998)
  • L.A. Campfield et al.

    The OB protein (leptin) pathway: A link between adipose tissue mass and central neural networks

    Horm. Metab. Res.

    (1996)
  • G.Y. Cao et al.

    Leptin receptors in the adrenal medulla of the rat

    Am. J. Physiol.

    (1997)
  • M. Caprio et al.

    Expression of functional leptin receptors in rodent Leydig cells

    Endocrinology

    (1999)
  • J.M. Cerda‐Reverter et al.

    Neuropeptide Y family of peptides: Structure, anatomical expression, function, and molecular evolution

    Biochem. Cell Biol.

    (2000)
  • Cited by (85)

    • Mechanistic insights on impact of Adenosine monophosphate-activated protein kinase (AMPK) mediated signalling pathways on cerebral ischemic injury

      2023, Neuroscience Research
      Citation Excerpt :

      It has been suggested that the central CRH system's high activity plays a primary role in aberrant HPA axis activation during ischemia and reperfusion (Pavlov et al., 2003; Gupta et al., 2021). Leptin, like other peptides, appears to regulate food intake and affects the HPA axis activity by acting on both its central and peripheral branches, according to growing data (Malendowicz et al., 2007). Leptin transmits negative feedback signals to the brain, suppressing HPA axis activation and decreasing food intake.

    • Animal Models of Metabolic Syndrome

      2017, Animal Models for the Study of Human Disease: Second Edition
    View all citing articles on Scopus
    View full text